Newstral
Article
Reuters on 2017-01-25 12:42
Novartis launches $5 billion share buyback, mulls Alcon spin-off
Related news
- Novartis Considers Alcon Spin-OffForbes
- Novartis slims down with $25bn spin-off of Alcon eyecare businessbusinessdayonline.com
- Novartis says 'never say never' to Alcon disposalReuters
- Struggling Alcon shows some progress as Novartis weighs spinoffStar Telegram
- FNovartis to spin off $25bn Alcon eyecare businessft.com
- Pharmakonzern Novartis treibt Alcon-Börsengang voranReuters
- Novartis replaces Alcon CEO, restructures its businessbizjournals.com
- Novartis mulls spinning off Sandoz generic drug unittimesofmalta.com
- BNovartis Stock Climbs. It's All About a Hike in Outlook and $15 Billion Share Buyback. 1 min readbarrons.com
- LNaphazoline Hydrochloride Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: Novartis AG, Alcon, Bausch & Lomb Inc, Allergan, Inc., Visine, Meda Pharmaceuti…liverpoolstudentmedia.com
- Novartis open global data center at Alcon in Fort WorthStar Telegram
- Fort Worth’s Alcon spun off Novartis, now trading on NYSEStar Telegram
- Trennung von Novartis kommt Augenheilkonzern Alcon teuer zu stehenReuters
- LSE launches £200m share buybacktimesofmalta.com
- UBS Plans $4.5 Billion Share Buybackwsj.com
- MABB launches new share buyback programmarketwatch.com
- General Motors in $5bn share buybackBBC
- Fortescue announces $500m share buyback programSydney Morning Herald
- Hilton sets $1 billion share buyback programmetro.us